✦ LIBER ✦

Utility of myocardial fractional flow reserve for prediction of restenosis following sirolimus-eluting stent implantation

✍ Scribed by Hideshi Ishii; Toru Kataoka; Yoshiki Kobayashi; Takara Tsumori; Hiroaki Takeshita; Ryo Matsumoto; Nobuyuki Shirai; Hiroki Nishioka; Takao Hasegawa; Shinji Nakata; Yoshihisa Shimada; Shoichi Ehara; Takashi Muro; Minoru Yoshiyama

Book ID: 106051071
Publisher: Springer
Year: 2011
Tongue: English
Weight: 385 KB
Volume: 26
Category: Article
ISSN: 0910-8327
DOI: 10.1007/s00380-010-0105-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Predictive factors of cardiac events aft

Predictive factors of cardiac events after implantation of sirolimus-eluting stents for treatment of in-stent restenosis

✍ Claude Le Feuvre; Gilles Montalescot; Guillaume Rosey; Jean P. Collet; Farzin Be 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 111 KB

USEFULNESS OF A TRANS-STENT FRACTIONAL F

USEFULNESS OF A TRANS-STENT FRACTIONAL FLOW RESERVE GRADIENT FOR ASSESSING THE RESULTS OF DRUG-ELUTING STENT IMPLANTATION

✍ Lim, Hong-Seok; Tahk, Seung-Jea; Yang, Hyoung-Mo; Yoon, Myeong-Ho; Choi, Byoung- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 118 KB

Predictive Factors of Re-restenosis afte

Predictive Factors of Re-restenosis after Repeated Sirolimus-Eluting Stent Implantation for SES Restenosis and Clinical Outcomes after Percutaneous Coronary Intervention for SES Restenosis

✍ KENICHI CHATANI; TOSHIYA MURAMATSU; REIKO TSUKAHARA; YOSHIAKI ITO; HIROSHI ISHIM 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB

Long-term safety and efficacy of sirolim

Long-term safety and efficacy of sirolimus- vs. paclitaxel-eluting stent implantation for acute ST-elevation myocardial infarction: 3-year follow-up of the PROSIT trial

✍ Hyun-Sook Kim; Jae-Hwan Lee; Seung-Whan Lee; Young-Hak Kim; Jae-Hyeong Park; Si- 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 343 KB

Two-by-two factorial comparison of high-

Two-by-two factorial comparison of high-bolus-dose tirofiban followed by standard infusion versus abciximab and sirolimus-eluting versus bare-metal stent implantation in patients with acute myocardial infarction: Design and rationale for the MULTI-STRATEGY trial

✍ Marco Valgimigli; Leonardo Bolognese; Maurizio Anselmi; Gianluca Campo; Alfredo 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 164 KB